PRESS RELEASES

Date	Title and Summary	Additional Formats
Toggle SummaryNov 18, 2013	Integra LifeSciences to Participate in the Piper Jaffray Healthcare and Oppenheimer Healthcare Conferences in December PLAINSBORO, N.J., Nov. 18, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at the following conferences next month: At 12:00 PM ET on Tuesday, December 3, 2013, Mr. Peter Arduini, President and Chief Executive Officer of Integra	View HTML Integra LifeSciences to Participate in the Piper Jaffray Healthcare and Oppenheimer Healthcare Conferences in December 11.1 KB
Toggle SummaryNov 6, 2013	Integra LifeSciences Prices Public Offering of Common Stock PLAINSBORO, N.J., Nov. 6, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has priced its previously announced underwritten public offering of 3,500,000 shares of its common stock at $40.00 per share.	View HTML Integra LifeSciences Prices Public Offering of Common Stock 13 KB
Toggle SummaryNov 4, 2013	Integra LifeSciences Announces Proposed Public Offering of Common Stock PLAINSBORO, N.J., Nov. 4, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it intends to offer, subject to market conditions and other factors, 3,500,000 shares of its common stock in an underwritten public offering registered under the	View HTML Integra LifeSciences Announces Proposed Public Offering of Common Stock 14 KB
Toggle SummaryOct 28, 2013	Integra LifeSciences Reports Third Quarter 2013 Financial Results Revenue In Line with Guidance Cash Flows from Operations of $31 Million PLAINSBORO, N.J., Oct. 28, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its financial results for the third quarter ending September 30, 2013.	View HTML Integra LifeSciences Reports Third Quarter 2013 Financial Results 52.5 KB
Toggle SummaryOct 28, 2013	Integra LifeSciences to Acquire DuraSeal(TM) Product Lines From Covidien PLAINSBORO, N.J., Oct. 28, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today it has entered into a definitive agreement with Covidien to acquire the Confluent Surgical product lines, including surgical sealants, adhesion barrier, and, most importantly,	View HTML Integra LifeSciences to Acquire DuraSeal(TM) Product Lines From Covidien 12.9 KB
Toggle SummaryOct 23, 2013	Integra LifeSciences Announces Update on Optimization Initiatives Plans Closure of Two Manufacturing Facilities Announces Additional Product Discontinuations Estimates Impairment to Goodwill in Spine Business PLAINSBORO, N.J., Oct. 23, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it plans to eliminate	View HTML Integra LifeSciences Announces Update on Optimization Initiatives 14.7 KB
Toggle SummaryOct 21, 2013	Integra LifeSciences Introduces Next-Generation Licox(R) Brain Tissue Oxygen Monitoring System Seamlessly Integrates With Camino(R) ICP Monitor	View HTML Integra LifeSciences Introduces Next-Generation Licox(R) Brain Tissue Oxygen Monitoring System 11.1 KB
Toggle SummaryOct 17, 2013	Integra LifeSciences Announces Launch of Integra(R) Proximal Humeral Fracture Plate System in United States Offers Surgeons Versatile Solution for Shoulder Fracture Treatment	View HTML Integra LifeSciences Announces Launch of Integra(R) Proximal Humeral Fracture Plate System in United States 10.3 KB
Toggle SummaryOct 11, 2013	Integra LifeSciences to Host Its Third Quarter 2013 Earnings Results Conference Call on October 28, 2013 PLAINSBORO, N.J., Oct. 11, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will release its third quarter 2013 financial results on Monday, October 28, 2013. The company has scheduled a conference call for 4:30 PM ET the same day to discuss the results.	View HTML Integra LifeSciences to Host Its Third Quarter 2013 Earnings Results Conference Call on October 28, 2013 9.8 KB
Toggle SummaryOct 10, 2013	Integra LifeSciences Receives FDA Clearance for Integra(R) Laminoplasty System PLAINSBORO, N.J., Oct. 10, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the introduction of the Integra ® Laminoplasty System, a comprehensive set of implants and instruments designed for use after open-door laminoplasty procedures in the cervical	View HTML Integra LifeSciences Receives FDA Clearance for Integra(R) Laminoplasty System 10.4 KB